Celsius Holdings, Inc. (NASDAQ:CELH) Receives $47.78 Consensus Target Price from Analysts

Shares of Celsius Holdings, Inc. (NASDAQ:CELH) have been given an average rating of “Moderate Buy” by the eighteen ratings firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have assigned a buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $47.78.

A number of analysts have issued reports on the stock. JPMorgan Chase & Co. assumed coverage on shares of Celsius in a research note on Thursday, December 12th. They set an “overweight” rating and a $37.00 price target on the stock. Needham & Company LLC increased their target price on shares of Celsius from $38.00 to $40.00 and gave the stock a “buy” rating in a report on Tuesday, February 25th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Celsius in a research note on Thursday, December 12th. They issued a “hold” rating and a $32.00 price target for the company. Jefferies Financial Group decreased their target price on Celsius from $44.00 to $40.00 and set a “buy” rating for the company in a report on Thursday, December 19th. Finally, Roth Mkm restated a “buy” rating and set a $38.00 price target on shares of Celsius in a report on Friday, February 21st.

Celsius Stock Down 1.2 %

Shares of CELH opened at $27.49 on Monday. Celsius has a 52-week low of $21.10 and a 52-week high of $99.62. The stock has a fifty day simple moving average of $25.88 and a two-hundred day simple moving average of $29.13. The company has a market capitalization of $6.46 billion, a PE ratio of 62.48, a price-to-earnings-growth ratio of 2.90 and a beta of 1.90.

Celsius (NASDAQ:CELH) last issued its quarterly earnings data on Thursday, February 20th. The company reported $0.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.11 by $0.03. Celsius had a return on equity of 51.89% and a net margin of 10.70%. The firm had revenue of $332.20 million during the quarter, compared to the consensus estimate of $326.07 million. As a group, equities analysts anticipate that Celsius will post 0.89 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Celsius news, insider Paul H. Storey sold 10,188 shares of the stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $25.77, for a total transaction of $262,544.76. Following the completion of the sale, the insider now directly owns 45,297 shares of the company’s stock, valued at approximately $1,167,303.69. This trade represents a 18.36 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On Celsius

Several hedge funds have recently modified their holdings of CELH. Champlain Investment Partners LLC acquired a new stake in shares of Celsius in the 4th quarter worth $85,068,000. Contrarius Group Holdings Ltd purchased a new stake in Celsius in the 4th quarter valued at approximately $75,535,000. Norges Bank acquired a new stake in shares of Celsius in the 4th quarter valued at approximately $72,579,000. Alyeska Investment Group L.P. boosted its position in shares of Celsius by 60.5% during the 4th quarter. Alyeska Investment Group L.P. now owns 6,877,918 shares of the company’s stock worth $181,164,000 after purchasing an additional 2,591,345 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in shares of Celsius during the 4th quarter valued at approximately $61,160,000. 60.95% of the stock is owned by institutional investors and hedge funds.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.